A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19

In December of 2019, an outbreak of a novel coronavirus flared in Wuhan, the capital city of the Hubei Province, China. The pathogen has been identified as a novel enveloped RNA beta-coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus SARS-CoV-2 is associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maciorowski, Dawid, El Idrissi, Samir Z., Gupta, Yash, Medernach, Brian J., Burns, Michael B., Becker, Daniel P., Durvasula, Ravi, Kempaiah, Prakasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Laboratory Automation and Screening. Published by Elsevier Inc. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960157/
https://www.ncbi.nlm.nih.gov/pubmed/32942923
http://dx.doi.org/10.1177/2472555220958385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960157/
https://www.ncbi.nlm.nih.gov/pubmed/32942923
http://dx.doi.org/10.1177/2472555220958385

Ejemplares similares